266 related articles for article (PubMed ID: 26576422)
1. Effects of Whole-Body Cryotherapy in Comparison with Other Physical Modalities Used with Kinesitherapy in Rheumatoid Arthritis.
Gizińska M; Rutkowski R; Romanowski W; Lewandowski J; Straburzyńska-Lupa A
Biomed Res Int; 2015; 2015():409174. PubMed ID: 26576422
[TBL] [Abstract][Full Text] [Related]
2. Effects of different local cryotherapies on systemic levels of TNF-α, IL-6, and clinical parameters in active rheumatoid arthritis.
Jastrząbek R; Straburzyńska-Lupa A; Rutkowski R; Romanowski W
Rheumatol Int; 2013 Aug; 33(8):2053-60. PubMed ID: 23397259
[TBL] [Abstract][Full Text] [Related]
3. Complex rehabilitation and the clinical condition of working rheumatoid arthritis patients: does cryotherapy always overtop traditional rehabilitation?
Księżopolska-Orłowska K; Pacholec A; Jędryka-Góral A; Bugajska J; Sadura-Sieklucka T; Kowalik K; Pawłowska-Cyprysiak K; Łastowiecka-Moras E
Disabil Rehabil; 2016; 38(11):1034-40. PubMed ID: 26853597
[TBL] [Abstract][Full Text] [Related]
4. The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis.
Hirvonen H; Kautiainen H; Moilanen E; Mikkelsson M; Leirisalo-Repo M
Rheumatol Int; 2017 Sep; 37(9):1481-1487. PubMed ID: 28698947
[TBL] [Abstract][Full Text] [Related]
5. [Serial whole-body cryotherapy in the criostream for inflammatory rheumatic diseases. A pilot study].
Lange U; Uhlemann C; Müller-Ladner U
Med Klin (Munich); 2008 Jun; 103(6):383-8. PubMed ID: 18548207
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of different cryotherapies on pain and disease activity in active rheumatoid arthritis. A randomised single blinded controlled trial.
Hirvonen HE; Mikkelsson MK; Kautiainen H; Pohjolainen TH; Leirisalo-Repo M
Clin Exp Rheumatol; 2006; 24(3):295-301. PubMed ID: 16870097
[TBL] [Abstract][Full Text] [Related]
7. Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles.
Klemm P; Becker J; Aykara I; Asendorf T; Dischereit G; Neumann E; Müller-Ladner U; Lange U
Adv Rheumatol; 2021 Jan; 61(1):3. PubMed ID: 33436106
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
Ingegnoli F; Fantini F; Favalli EG; Soldi A; Griffini S; Galbiati V; Meroni PL; Cugno M
J Autoimmun; 2008 Sep; 31(2):175-9. PubMed ID: 18707846
[TBL] [Abstract][Full Text] [Related]
9. Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6.
Straub RH; Pongratz G; Hirvonen H; Pohjolainen T; Mikkelsson M; Leirisalo-Repo M
Ann Rheum Dis; 2009 Apr; 68(4):572-8. PubMed ID: 18413439
[TBL] [Abstract][Full Text] [Related]
10. Cryotherapy decreases histamine levels in the blood of patients with rheumatoid arthritis.
Wojtecka-Lukasik E; Ksiezopolska-Orlowska K; Gaszewska E; Krasowicz-Towalska O; Rzodkiewicz P; Maslinska D; Szukiewicz D; Maslinski S
Inflamm Res; 2010 Mar; 59 Suppl 2():S253-5. PubMed ID: 20020313
[TBL] [Abstract][Full Text] [Related]
11. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
12. [Rheumatoid arthritis with physical disability and its rehabilitation: with special reference to the effect of cryomassage].
Nobunaga T; Yamauchi S
Ryumachi; 1977 Mar; 17(2):232-5. PubMed ID: 141108
[No Abstract] [Full Text] [Related]
13. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
14. Effects of Alpha-Lipoic Acid Supplementation on Inflammatory Biomarkers and Matrix Metalloproteinase-3 in Rheumatoid Arthritis Patients.
Mirtaheri E; Gargari BP; Kolahi S; Dehghan P; Asghari-Jafarabadi M; Hajalilou M; Shakiba Novin Z; Mesgari Abbasi M
J Am Coll Nutr; 2015; 34(4):310-7. PubMed ID: 25751300
[TBL] [Abstract][Full Text] [Related]
15. The practice of physical activity and cryotherapy in rheumatoid arthritis: systematic review.
Peres D; Sagawa Y; Dugué B; Domenech SC; Tordi N; Prati C
Eur J Phys Rehabil Med; 2017 Oct; 53(5):775-787. PubMed ID: 27996221
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis.
Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S
J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318
[TBL] [Abstract][Full Text] [Related]
17. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[TBL] [Abstract][Full Text] [Related]
18. [Combined step-by-step rehabilitation of the patients presenting with early-onset rheumatoid arthritis].
Orlova EV; Karateev DE; Kochetkov AV; Denisov LN; Surnov AV
Vopr Kurortol Fizioter Lech Fiz Kult; 2013; (1):44-50. PubMed ID: 23520927
[TBL] [Abstract][Full Text] [Related]
19. Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology.
Piga M; Tradori I; Pani D; Barabino G; Dessì A; Raffo L; Mathieu A
J Rheumatol; 2014 Jul; 41(7):1324-33. PubMed ID: 24882841
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
